Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

No Magic Pill: A Prescription for Enhanced Shared Decision-Making for Depression Treatment.

Cosgrove L, Erlich D, Shaughnessy AF.

J Am Board Fam Med. 2019 Jan-Feb;32(1):6-9. doi: 10.3122/jabfm.2019.01.180182.

2.

Triangle Method: Teaching the Student in Front of the Patient.

Erlich DR.

Acad Med. 2018 Dec 31. doi: 10.1097/ACM.0000000000002574. [Epub ahead of print] No abstract available.

PMID:
30608268
3.

Glecaprevir/Pibrentasvir (Mavyret) for the Treatment of Chronic Hepatitis C.

Grover A, Erlich DR.

Am Fam Physician. 2018 Nov 15;98(10):601-602. No abstract available.

PMID:
30365290
4.

Developing a Clinician Friendly Tool to Identify Useful Clinical Practice Guidelines: G-TRUST.

Shaughnessy AF, Vaswani A, Andrews BK, Erlich DR, D'Amico F, Lexchin J, Cosgrove L.

Ann Fam Med. 2017 Sep;15(5):413-418. doi: 10.1370/afm.2119.

5.

'We rise by lifting others': peer support and professional development for women in academic medicine.

Erlich DR, Cohen-Osher MB, Goodell KH.

Educ Prim Care. 2017 Sep;28(5):291-294. doi: 10.1080/14739879.2017.1293476. Epub 2017 Feb 24. No abstract available.

PMID:
28234552
6.

Cigarette Smoking Is Associated With Increased Risk of Substance Use Disorder Relapse: A Nationally Representative, Prospective Longitudinal Investigation.

Weinberger AH, Platt J, Esan H, Galea S, Erlich D, Goodwin RD.

J Clin Psychiatry. 2017 Feb;78(2):e152-e160. doi: 10.4088/JCP.15m10062.

7.

Evolocumab (Repatha) for the Treatment of Hyperlipidemia.

Erlich DR.

Am Fam Physician. 2016 Nov 15;94(10):843-846. No abstract available.

8.

Glycemic control is an important consideration in diabetes care. In reply.

Erlich DR, Slawson DC, Shaughnessy AF.

Am Fam Physician. 2014 Oct 15;90(8):524-6. No abstract available.

9.

Type 2 Diabetes: Updated Evidence Requires Updated Decision Making.

Shaughnessy AF, Erlich DR, Slawson DC.

Am Fam Physician. 2015 Jul 1;92(1):22. No abstract available.

10.

"Lending a hand" to patients with type 2 diabetes: a simple way to communicate treatment goals.

Erlich DR, Slawson DC, Shaughnessy AF.

Am Fam Physician. 2014 Feb 15;89(4):256, 258. No abstract available.

11.

Student-teacher education programme (STEP) by step: transforming medical students into competent, confident teachers.

Erlich DR, Shaughnessy AF.

Med Teach. 2014 Apr;36(4):322-32. doi: 10.3109/0142159X.2014.887835. Epub 2014 Mar 5.

PMID:
24597597
12.

Conflicts of interest and the quality of recommendations in clinical guidelines.

Cosgrove L, Bursztajn HJ, Erlich DR, Wheeler EE, Shaughnessy AF.

J Eval Clin Pract. 2013 Aug;19(4):674-81. doi: 10.1111/jep.12016. Epub 2012 Dec 21.

PMID:
23731207
13.

Diabetes update: population management.

Erlich DR, Slawson DC, Shaughnessy A.

FP Essent. 2013 May;408:25-33. Review.

PMID:
23690376
14.

Diabetes update: new drugs to manage type 2 diabetes.

Erlich DR, Slawson DC, Shaughnessy A.

FP Essent. 2013 May;408:20-4. Review.

PMID:
23690375
15.

Diabetes update: long-term treatment of adults.

Erlich DR, Slawson DC, Shaughnessy A.

FP Essent. 2013 May;408:14-9.

PMID:
23690374
16.

Diabetes update: screening and diagnosis.

Erlich DR, Slawson DC, Shaughnessy A.

FP Essent. 2013 May;408:11-3.

PMID:
23690373
17.

Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation.

Marduel M, Ouguerram K, Serre V, Bonnefont-Rousselot D, Marques-Pinheiro A, Erik Berge K, Devillers M, Luc G, Lecerf JM, Tosolini L, Erlich D, Peloso GM, Stitziel N, Nitchké P, Jaïs JP; French Research Network on ADH, Abifadel M, Kathiresan S, Leren TP, Rabès JP, Boileau C, Varret M.

Hum Mutat. 2013 Jan;34(1):83-7. doi: 10.1002/humu.22215. Epub 2012 Oct 11.

18.

The effect of personal lifestyle intervention among health care providers on their patients and clinics; the Promoting Health by Self Experience (PHASE) randomized controlled intervention trial.

Shai I, Erlich D, Cohen AD, Urbach M, Yosef N, Levy O, Shahar DR.

Prev Med. 2012 Oct;55(4):285-291. doi: 10.1016/j.ypmed.2012.08.001. Epub 2012 Aug 12.

PMID:
22906808
19.

Sleeping at home: a new model for a hospital teaching service.

Erlich DR, Shaughnessy AF.

J Grad Med Educ. 2011 Jun;3(2):243-5. doi: 10.4300/JGME-D-10-00098.1. No abstract available.

20.

Tapentadol (nucynta) for treatment of pain.

Erlich DR, Bodine W.

Am Fam Physician. 2012 May 1;85(9):910-1. No abstract available. Erratum in: Am Fam Physician. 2012 Jul 1;86(1):8.

21.

Ability of an information mastery curriculum to improve residents' skills and attitudes.

Shaughnessy AF, Gupta PS, Erlich DR, Slawson DC.

Fam Med. 2012 Apr;44(4):259-64.

22.

Molecular spectrum of autosomal dominant hypercholesterolemia in France.

Marduel M, Carrié A, Sassolas A, Devillers M, Carreau V, Di Filippo M, Erlich D, Abifadel M, Marques-Pinheiro A, Munnich A, Junien C; French ADH Research Network, Boileau C, Varret M, Rabès JP.

Hum Mutat. 2010 Nov;31(11):E1811-24. doi: 10.1002/humu.21348.

23.

A fourth locus for autosomal dominant hypercholesterolemia maps at 16q22.1.

Marques-Pinheiro A, Marduel M, Rabès JP, Devillers M, Villéger L, Allard D, Weissenbach J, Guerin M, Zair Y, Erlich D, Junien C, Munnich A, Krempf M, Abifadel M, Jaïs JP; French Research Network on ADH, Boileau C, Varret M.

Eur J Hum Genet. 2010 Nov;18(11):1236-42. doi: 10.1038/ejhg.2010.94. Epub 2010 Jun 23.

24.

Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease.

Abifadel M, Rabès JP, Devillers M, Munnich A, Erlich D, Junien C, Varret M, Boileau C.

Hum Mutat. 2009 Apr;30(4):520-9. doi: 10.1002/humu.20882. Review.

PMID:
19191301
25.

A PCSK9 variant and familial combined hyperlipidaemia.

Abifadel M, Bernier L, Dubuc G, Nuel G, Rabès JP, Bonneau J, Marques A, Marduel M, Devillers M, Munnich A, Erlich D, Varret M, Roy M, Davignon J, Boileau C.

J Med Genet. 2008 Dec;45(12):780-6. doi: 10.1136/jmg.2008.059980. Epub 2008 Aug 15.

PMID:
18708425
26.

Evaluation of renal function in intensive care: plasma cystatin C vs. creatinine and derived glomerular filtration rate estimates.

Le Bricon T, Leblanc I, Benlakehal M, Gay-Bellile C, Erlich D, Boudaoud S.

Clin Chem Lab Med. 2005;43(9):953-7.

PMID:
16176176
27.

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.

Abifadel M, Varret M, Rabès JP, Allard D, Ouguerram K, Devillers M, Cruaud C, Benjannet S, Wickham L, Erlich D, Derré A, Villéger L, Farnier M, Beucler I, Bruckert E, Chambaz J, Chanu B, Lecerf JM, Luc G, Moulin P, Weissenbach J, Prat A, Krempf M, Junien C, Seidah NG, Boileau C.

Nat Genet. 2003 Jun;34(2):154-6.

PMID:
12730697
28.

Prevalence, risk factors and outcome of hyperlactataemia in HIV-infected patients.

Hocqueloux L, Alberti C, Feugeas JP, Lafaurie M, Lukasiewicz E, Bagnard G, Carel O, Erlich D, Molina JM.

HIV Med. 2003 Jan;4(1):18-23.

29.

Urinary free light chain analysis by the Freelite immunoassay: a preliminary study in multiple myeloma.

Le Bricon T, Bengoufa D, Benlakehal M, Bousquet B, Erlich D.

Clin Biochem. 2002 Oct;35(7):565-7.

PMID:
12493586
30.

Exercise training-induced triglyceride lowering negatively correlates with DHEA levels in men with type 2 diabetes.

Boudou P, de Kerviler E, Erlich D, Vexiau P, Gautier JF.

Int J Obes Relat Metab Disord. 2001 Aug;25(8):1108-12.

PMID:
11477494
31.

Early diagnosis of renal function recovery by cystatin C in renal allograft recipients.

Thervet E, Le Bricon T, Hugot V, Benlakehal M, Bedrossian J, Beuzard Y, Legendre C, Erlich D.

Transplant Proc. 2000 Dec;32(8):2779. No abstract available.

PMID:
11134801
32.

Autosomal dominant type IIa hypercholesterolemia: evaluation of the respective contributions of LDLR and APOB gene defects as well as a third major group of defects.

Saint-Jore B, Varret M, Dachet C, Rabès JP, Devillers M, Erlich D, Blanchard P, Krempf M, Mathé D, Chanu B, Jacotot B, Farnier M, Bonaïti-Péllié C, Junien C, Boileau C.

Eur J Hum Genet. 2000 Aug;8(8):621-30.

33.

Plasma cystatin C is superior to 24-h creatinine clearance and plasma creatinine for estimation of glomerular filtration rate 3 months after kidney transplantation.

Le Bricon T, Thervet E, Froissart M, Benlakehal M, Bousquet B, Legendre C, Erlich D.

Clin Chem. 2000 Aug;46(8 Pt 1):1206-7. No abstract available.

34.

Changes in plasma cystatin C after renal transplantation and acute rejection in adults.

Le Bricon T, Thervet E, Benlakehal M, Bousquet B, Legendre C, Erlich D.

Clin Chem. 1999 Dec;45(12):2243-9.

35.

[Determinations of urine protein concentration and plasma replacement therapy].

Le Bricon T, Boudaoud S, Chenebit A, Viguier D, Erlich D, Bousquet B.

Ann Biol Clin (Paris). 1999 Jan-Feb;57(1):108-9. French. No abstract available.

36.

[Determination of total proteinuria: a comparative study of automated trichloracetic acid and pyrogallol red techniques for samples with monoclonal light chains].

Le Bricon T, Erlich D, Dussaucy M, Garnier JP, Bousquet B.

Ann Biol Clin (Paris). 1998 Nov-Dec;56(6):719-23. French. No abstract available.

37.

Sodium dodecyl sulfate-agarose gel electrophoresis of urinary proteins: application to multiple myeloma.

Le Bricon T, Erlich D, Bengoufa D, Dussaucy M, Garnier JP, Bousquet B.

Clin Chem. 1998 Jun;44(6 Pt 1):1191-7.

38.

Familial ligand-defective apolipoprotein B-100: simultaneous detection of the ARG3500-->GLN and ARG3531-->CYS mutations in a French population.

Rabès JP, Varret M, Saint-Jore B, Erlich D, Jondeau G, Krempf M, Giraudet P, Junien C, Boileau C.

Hum Mutat. 1997;10(2):160-3.

PMID:
9259199
39.

Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes.

Ruiz J, Thillet J, Huby T, James RW, Erlich D, Flandre P, Froguel P, Chapman J, Passa P.

Diabetologia. 1994 Jun;37(6):585-91.

PMID:
7926343
40.

Lipoprotein(a) in diabetic patients and normoglycemic relatives in familial NIDDM.

Velho G, Erlich D, Turpin E, Néel D, Cohen D, Froguel P, Passa P.

Diabetes Care. 1993 May;16(5):742-7.

PMID:
8495614
41.

Some aspects of the use of dextran sulfate-cellulose columns for the treatment of familial hypercholesterolemia.

Erlich D, Aubert I, Neel D, Scrobohaci ML, Loreau J, Bussel A, Rouffy J, Dreux C, Goussault Y, Weintraub H.

Clin Chim Acta. 1991 Sep 30;201(3):169-74. No abstract available.

PMID:
1756589
42.

Efficacy and safety of simvastatin (alone or in association with cholestyramine). A 1-year study in 66 patients with type II hyperlipoproteinaemia.

Emmerich J, Aubert I, Bauduceau B, Dachet C, Chanu B, Erlich D, Gautier D, Jacotot B, Rouffy J.

Eur Heart J. 1990 Feb;11(2):149-55.

PMID:
2178931
43.

LDL apheresis by dextran sulfate cellulose (DSC) column in two patients with monogenic familial hypercholesterolemia (FH).

Aubert I, Bombail D, Erlich D, Goussault Y, Rouffy J, Bussel A.

Prog Clin Biol Res. 1990;337:205-7. No abstract available.

PMID:
1693782
44.

[Removal of low density lipoproteins on dextrans sulfate in 2 patients with familial monogenic hypercholesterolemia].

Aubert I, Bombail D, Erlich D, Goy-Loeper J, Chanu B, Bussel A, Rouffy J.

Ann Med Interne (Paris). 1988;139 Suppl 1:72-6. French.

PMID:
2470281
45.

Plasma lipids in juvenile chronic granulocytic leukaemia.

Turpin E, Leverger G, Erlich D, Neel D, Beaudry P, Dreux C, Goussault Y, Schaison G.

Eur J Haematol. 1987 Jul;39(1):14-7.

PMID:
3477469
46.

Specific modulation of surface receptors in J.774 macrophages by anchorage.

Ventura MA, Louache F, Rouis M, Erlich D, Goldstein S, Testa U, Thomopoulos P.

Exp Cell Res. 1987 Jun;170(2):290-9.

PMID:
3036550
47.

Identification of specific binding sites for acetylated low density lipoprotein in microvillous membranes from human placenta.

Alsat E, Mondon F, Rebourcet R, Berthelier M, Erlich D, Cedard L, Goldstein S.

Mol Cell Endocrinol. 1985 Jul;41(2-3):229-35.

PMID:
4018398
48.

The cholesterol content of HDL2 and HDL3 subfractions of high density lipoproteins in different normocholesterolemic populations.

Neel D, Beaudry P, Erlich D, Turpin E, Goussault Y, Dreux C.

Clin Chim Acta. 1984 Oct 15;142(3):319-24.

PMID:
6488565
49.

[Homologous bone preserved in glycerin: experimental study in guinea pigs].

Marques A, Freire Leite JB, Marziona F, Filho OG, Moreira FA, Abrão FS, Gentil FC, Magrin J, Erlich DH.

Rev Paul Med. 1980 Jan-Feb;95(1-2):14-9. Portuguese. No abstract available.

PMID:
6996068
50.

[Evaluation of heterologous dura mater as a dura substitute: experimental study in dogs].

Marques AF, Leite JB, Tanaka H, Ueda M, Giannotti Filho O, Weigl DR, Precoppe JR, Gomes OM, Erlich DH, Pigossi N.

Rev Paul Med. 1978 Nov-Dec;92(5-6):89-94. Portuguese. No abstract available.

PMID:
746284

Supplemental Content

Loading ...
Support Center